NCT06568224View on ClinicalTrials.gov

Therapeutic Effect of Methalazine on 27 Cases of Suppurative Hidradenitis

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
Hidradenitis Suppurativa
Interventions
DRUG

Mesalazine

oral mesalazine 1g qid

Trial Locations (1)

210029

Jiangsu Provincial People's Hospital, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT06568224 - Therapeutic Effect of Methalazine on 27 Cases of Suppurative Hidradenitis | Biotech Hunter | Biotech Hunter